Edwards Lifesciences Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2019
Total Assets: $6.49B
Liabilities Breakdown FY2019
Total Liabilities: $2.34B
Asset Breakdown
Total Assets: $6.49B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.18B | 18.2% |
| Accounts Receivable | $543.6M | 8.4% |
| Inventory | $640.9M | 9.9% |
| Property, Plant & Equipment | $1.06B | 16.3% |
| Goodwill | $1.17B | 18.0% |
| Intangible Assets | $336.5M | 5.2% |
| Other Assets | $1.56B | 24.0% |
Liabilities Breakdown
Total Liabilities: $2.34B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $180.4M | 7.7% |
| Long-Term Debt | $594.4M | 25.4% |
| Other Liabilities | $1.57B | 66.9% |